Tetsuo Taguchi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Tetsuo Taguchi

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009

Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumorsTaroh Satoh, Isamu Okamoto, Masaki Miyazaki, et al.

Biomarker Research|March 24, 2021

Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibodyYutaro Kaneko, Ryo Hatano, Naoto Hirota, et al.

International Journal of Oncology|February 12, 2002

The effect of adjuvant 5'-deoxy-5-fluorouridine in early stage breast cancer patients: results from a multicenter randomized controlled trialTakeshi Tominaga, Masakazu Toi, Osahiko Abe, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009

Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumorsTaroh Satoh, Isamu Okamoto, Masaki Miyazaki, et al.

Biomarker Research|March 24, 2021

Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibodyYutaro Kaneko, Ryo Hatano, Naoto Hirota, et al.

International Journal of Oncology|February 12, 2002

The effect of adjuvant 5'-deoxy-5-fluorouridine in early stage breast cancer patients: results from a multicenter randomized controlled trialTakeshi Tominaga, Masakazu Toi, Osahiko Abe, et al.

Pageof 4